Search company, investor...

Founded Year

2015

Stage

Series B - II | Alive

Total Raised

$71.02M

Last Raised

$31.38M | 2 yrs ago

About SUMGEN

SUMGEN operates as an innovation-driven biopharmaceutical company. It develops and commercializes innovative antibody drugs for major diseases such as malignant tumors. The company was founded in 2015 and is based in Hangzhou, China.

Headquarters Location

Room 101, Floor 1, Building C, Building 2, No. 688, Bin'an Road, Changhe Street Binjiang District

Hangzhou, Zhejiang ,

China

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

SUMGEN Patents

SUMGEN has filed 7 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immunology
  • Monoclonal antibodies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/11/2019

8/1/2023

Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system

Grant

Application Date

2/11/2019

Grant Date

8/1/2023

Title

Related Topics

Clusters of differentiation, Monoclonal antibodies, Immunology, Transcription factors, Immune system

Status

Grant

Latest SUMGEN News

Sumgen Completes $32 Million Round for Immunotherapy Antibodies

Oct 1, 2020

publication date: Oct 1, 2020 Sumgen Biotech of Hangzhou completed a $32 million Series B funding round to advance its portfolio of novel immunotherapy antibodies. The round was led by Addor Capital and co-led by Cowin Capital and Sinowisdom Investment. The proceeds will be used to fund clinical trials of the company's pipeline of ten oncology mAbs and construction of an antibody production facility in Hangzhou Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

SUMGEN Frequently Asked Questions (FAQ)

  • When was SUMGEN founded?

    SUMGEN was founded in 2015.

  • Where is SUMGEN's headquarters?

    SUMGEN's headquarters is located at Room 101, Floor 1, Building C, Building 2, No. 688, Bin'an Road, Changhe Street, Hangzhou.

  • What is SUMGEN's latest funding round?

    SUMGEN's latest funding round is Series B - II.

  • How much did SUMGEN raise?

    SUMGEN raised a total of $71.02M.

  • Who are the investors of SUMGEN?

    Investors of SUMGEN include Addor Capital, ZheShang Venture Capital, Junchuan Capital, Hankang Equity Investment Management, Wanhui Capital and 10 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.